A model incorporating dynamic contrast material-enhanced and diffusion-weighted MR features could help identify women with high-risk ductal carcinoma in situ (DCIS), which may provide information to facilitate lesion-specific targeted therapies, according to a study published in the May issue of
Radiology.
Women between the ages of 40 and 49 years who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors than symptomatic women requiring diagnostic workup, according to a study published in the May issue of
American Journal of Roentgenology.
Radiotherapy treatment (RT) after surgery for ductal carcinoma in situ (DCIS) has a major protective effect against recurrence more than 15 years later, according to the results of an international trial presented March 22 at the 8th European Breast Cancer Conference (EBCC-8).
New England Journal of Medicine tackled the tough topic of mammography screening recommendations given the “considerable confusion and controversy,” resulting from the revision of U.S. Preventative Services Task Force guidelines in November 2009. After reviewing the evidence, Ellen Warner, MD, of the division of medical oncology at Sunnybrook Health Sciences Centre at University of Toronto, suggested screening mammography for most women ages 40 to 70.
The U.S. Preventive Services Task Force (USPSTF) ignited a breast imaging firestorm in November 2009. In the midst of a recent flare-up,
Health Imaging & IT examines the impact of the guidelines.
A pair of editorials in the September issue of
Radiology tackled the tough topic of breast cancer overdiagnosis by screening mammography. On one side, breast imagers argued that claims of overdiagnosis are inflated. On the other, a group of researchers suggested that screening mammography has a minor effect on mortality and breast imaging may cause more harm than benefit.
Women with mammographically dense breasts not only face a higher risk of breast cancer, but their tumors also are more likely to have more aggressive characteristics than women with less dense breasts, according to a study published online July 27 in the
Journal of the National Cancer Institute.
As many as one-fourth of cases of ductal carcinoma in situ (DCIS) diagnosed using core-needle biopsy are in fact understaged invasive breast cancers, according to a study published in the July issue of
Radiology.
